About BigHat
BigHat is a company based in San Carlos (United States) founded in 2019 by Peyton Greenside and Mark DePristo. BigHat has raised $148.41 million across 3 funding rounds from investors including Bristol-Myers Squibb, Amgen Business Development and Quadrille Capital. BigHat has completed 1 acquisition, including BigHat Biosciences. BigHat offers products and services including Milliner Platform. BigHat operates in a competitive market with competitors including argenx, MacroGenics, Owkin, Formation Bio and Alexion, among others.
- Headquarter San Carlos, United States
- Founders Peyton Greenside, Mark DePristo
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$148.41 M (USD)
in 3 rounds
-
Latest Funding Round
$124.11 M (USD), Series B
Jun 30, 2022
-
Investors
Bristol-Myers Squibb
& 9 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BigHat
BigHat offers a comprehensive portfolio of products and services, including Milliner Platform.
Integrates machine learning and wet lab for faster antibody engineering and design
People of BigHat
Unlock access to complete
Unlock access to complete
Funding Insights of BigHat
BigHat has successfully raised a total of $148.41M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $124.11 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BigHat
BigHat has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Bristol-Myers Squibb, Amgen Business Development and Quadrille Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are facilitated by Amgen-backed entity.
|
Locked | Locked | Locked | |
|
Sector-agnostic investment company making venture capital investments globally
|
Locked | Locked | Locked | |
|
Venture capital investing with a focus on diversity and inclusion in the ecosystem.
|
Locked | Locked | Locked |
Investor details for BigHat
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BigHat
BigHat has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include BigHat Biosciences.
Investment portfolio details for BigHat
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Synthetic biology platform provided for diagnostic and therapeutic applications.
|
Locked | Locked | 1976 | Locked |
Complete acquisition details for BigHat
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - BigHat
Detailed financials for BigHat
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bighat Comparisons
Peer comparison for BigHat
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BigHat
BigHat operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as argenx, MacroGenics, Owkin, Formation Bio and Alexion, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company focused on cancer therapeutics development.
|
|
| Locked | Locked | Locked |
An agentic AI platform is developed for biomedical research insights.
|
|
| Locked | Locked | Locked |
AI-powered drug discovery platform for various diseases
|
|
| Locked | Locked | Locked |
Therapies for rare and devastating diseases are developed by Alexion.
|
|
| Locked | Locked | Locked |
Antibody-based therapies for cancers and inflammatory diseases are developed.
|
Detailed competitors of BigHat
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bighat
Complete news archive for BigHat
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BigHat
BigHat was founded in 2019.
BigHat is headquartered in San Carlos, United States. It is registered at San Carlos, California, United States.
Mark DePristo is the current CEO of BigHat. They have also founded this company.
BigHat is a funded company, having raised a total of $148.41M across 3 funding rounds to date.
BigHat was founded in 2019 and is based in San Carlos, United States. Antibody therapies are provided by the company using machine learning and synthetic biology. An AI-enabled platform called Milliner is offered to design antibodies targeting intractable conditions, including chronic illnesses and life-threatening diseases. Operations focus on the biotechnology sector, with services aimed at therapeutic development for complex health challenges.
BigHat's top competitors include argenx, Owkin and Formation Bio.
BigHat offers Milliner Platform.
BigHat has made 1 acquisition, including BigHat Biosciences.
BigHat has 10 investors. Key investors include Bristol-Myers Squibb, Amgen Business Development, Quadrille Capital, Gaingels, and GRIDS Capital.